GLPG.AS

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$27M	-90.2%	$-2.95	$-3.96–$-1.78	—	1
2027	$41M	+53.5%	$-2.22	$-2.71–$-1.73	—	2
2028	$20M	-51.1%	$-2.77	$-3.71–$-1.67	—	1
2029	$34M	+68.7%	$-2.08	$-2.79–$-1.25	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 4 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-05-06	$-0.82	$0.21	+125.8%
2026-02-23	$-0.11	$11.87	+10890.9%
2025-11-05	$5.16	$-3.07	-159.4%
2025-07-23	$-0.34	$-1.60	-366.6%
2025-04-23	$-0.19	$-2.33	-1126.3%
2025-02-12	$-0.69	$0.38	+155.1%
2024-10-31	$-0.49	$-0.77	-57.1%
2024-08-01	$-0.21

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
GLPG.ASLakefront Biotherapeutics	$26.28	+2.26%	$1.7B	—
AD.ASKoninklijke Ahold Delhaize N.V.	$31.96	+0.53%	$28.2B	—
ARGX.BRargenx SE	$858.80	-1.04%	$53.4B	—
ASMBAssembly Biosciences, Inc.	$25.69	-11.29%	$509M	—
BAR.BRBarco N.V.	$7.37

Lakefront Biotherapeutics

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

lakefrontbio.com

Employees: 452
IPO / List date: Apr 14, 2005
HQ: BE

Held by traders on TradeandTell

No one on the platform currently holds GLPG.AS.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in GLPG.AS as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded GLPG.AS yet.